Predictive Oncology Dividenda 2024

Detalji o dividendama

Razumevanje dividendnih isplata od Predictive Oncology

Dividende od Predictive Oncology su deo profita kompanije koji se distribuira akcionarima. One su ključni indikator finansijskog zdravlja kompanije i atraktivnosti za investitore. Dividende pružaju investitorima stabilan izvor prihoda, pored dobiti koja se možda može ostvariti prodajom akcija po višoj ceni od kupovne.

Poređenje iz godine u godinu

Analiza isplata dividendi od Predictive Oncology tokom godina može istaći profitabilnost i stabilnost kompanije. Konstantno ili rastuće isplate dividendi mogu ukazivati na finansijski zdravu kompaniju sa predvidivim profitom, dok fluktuacije ili smanjenja dividendi mogu signalizirati osnovne finansijske ili operativne izazove.

Uticaj na investicije

Isplate dividendi od Predictive Oncology su suštinski faktor za investitore orijentisane na prihod. Robusna isplata dividendi može povećati privlačnost akcije i pružiti redovni prihod pored potencijalnih kapitalnih dobitaka. Ona može takođe pokazati poverenje kompanije u njene buduće profite i time biti značajan faktor za odlučivanje o investicijama.

Interpretacija fluktuacija dividendi

Promene u dividendama od Predictive Oncology mogu proistići iz promena u profitima kompanije, finansijskoj politici ili strategijama reinvestiranja. Povećanje dividendi često signalizira finansijsku stabilnost, dok smanjenje može ukazivati na potrebu da se sačuva gotovina ili da se profiti reinvestiraju radi podsticanja rasta, pri čemu svaki scenario ima različite posledice za investitore.

Predictive Oncology Aktienanalyse

Шта ради Predictive Oncology?

Predictive Oncology Inc is an emerging company in the field of cancer research and treatment. It was founded in 2002 under the name Precision Therapeutics and has since focused on developing new diagnostic and therapeutic procedures for cancer. The business model of Predictive Oncology is based on collaboration with pharmaceutical companies and research institutions to develop new technologies and products for cancer therapy. The focus is on personalized medicine, which enables treatment options tailored to individual patient needs. The company is divided into several divisions, each covering different areas of cancer research. These include predictive medicine, pharmacy, and diagnostics. Predictive Oncology has developed several products that can be used in predictive medicine. This includes the OncoTect iOCT System, which allows prediction of the effectiveness of chemotherapy for a specific type of cancer. Based on genetic analysis, the system can determine before treatment whether the drug used for chemotherapy is actually effective or if another drug may be more suitable. Another important product of Predictive Oncology is the Skyline Ventures Test Kit, which is used in pharmacy. The kit allows pharmaceutical companies to test the potential effect of a new drug on specific cancer cells before testing it on patients in clinical trials. By pre-testing the effectiveness, unnecessary studies can be avoided and the development of new drugs can be accelerated. In the field of diagnostics, Predictive Oncology has developed the Cchek system, which enables early detection of certain types of cancer through RNA analysis. The system can provide indications of the development of a tumor at an early stage, enabling early treatment. One of the recent developments of Predictive Oncology is the acquisition of Soluble Therapeutics Inc, which specializes in protein analysis. Through the acquisition, Predictive Oncology hopes to further increase its capacities in personalized cancer treatment. Overall, Predictive Oncology is one of the leading companies in the field of cancer research. Through a consistent focus on personalized medicine and close collaboration with research institutions and pharmaceutical companies, the company has already produced some promising developments. In the future, it is expected that Predictive Oncology will bring further innovative products and technologies to the market to treat cancer patients more effectively. Predictive Oncology je jedna od najpopularnijih kompanija na Eulerpool.com.

Često postavljana pitanja o Predictive Oncology akciji

Kolika je dividenda koju isplaćuje Predictive Oncology?

U poslednjih 12 meseci, Predictive Oncology je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Predictive Oncology će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Predictive Oncology?

Dividendski prinos od Predictive Oncology trenutno iznosi .

Kada Predictive Oncology isplaćuje dividendu?

Predictive Oncology isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Predictive Oncology?

Predictive Oncology je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Predictive Oncology?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Predictive Oncology?

Predictive Oncology se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Predictive Oncology kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Predictive Oncology od 1. 7. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 1. 7. 2024..

Kada je Predictive Oncology poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 1. 7. 2024..

Kolika je bila dividenda od Predictive Oncology u godini 2023?

U godini 2023 kompanija Predictive Oncology je isplatila 0 USD kao dividende.

U kojoj valuti Predictive Oncology isplaćuje dividendu?

Dividende od Predictive Oncology se isplaćuju u USD.